Currently out of the existing stock ratings of Ross Muken, 73 are a BUY (53.68%), 54 are a HOLD (39.71%), 9 are a SELL (6.62%).

Ross Muken

Work Performance Price Targets & Ratings Chart

Analyst Ross Muken, carries an average stock price target met ratio of 87.28% that have a potential upside of 15.99% achieved within 416 days. Previously, Ross Muken worked at EVERCORE.

Ross Muken’s has documented 278 price targets and ratings displayed on 27 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on CRL, Charles River Laboratories at 13-Jan-2026.

Wall Street Analyst Ross Muken

Analyst best performing recommendations are on PDCO (PATTERSON COMPANIES).
The best stock recommendation documented was for PDCO (PATTERSON COMPANIES) at 6/21/2018. The price target of $18.5 was fulfilled within 1 day with a profit of $0.73 (4.11%) receiving and performance score of 41.08.

Average potential price target upside

DGX Quest Diagnostics ICLR ICON PLC MCK McKesson PDCO Patterson Companies RAD Rite Aid A Agilent Technologies ABC AmerisourceBergen ATHN athenahealth CAH Cardinal Health HSIC Henry Schein WBA Walgreens Boots Alliance CERN Cerner Corp ILMN Illumina IQV IQVIA Holdings LH Laboratory of America Holdings Q Quintiles Transnational QGEN Qiagen NV TMO Thermo Fisher Scientific TWST Twist Bioscience Corp EHTH eHealth CRL Charles River Laboratories CVS CVS Health Corp DHR Danaher MDRX Allscripts Healthcare Solutions PINC Premier WAT Waters ONVO Organovo Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Jan-2017

$235

$32.59 (16.10%)

$210

11 days ago
(12-Feb-2026)

23/25 (92%)

$28.14 (13.60%)

540

Buy Since 10-Dec-2024

$220

$17.59 (8.69%)

$215

12 days ago
(11-Feb-2026)

1/3 (33.33%)

$10.68 (5.10%)

287

Buy Since 11-Feb-2026

$225

$22.59 (11.16%)

$195

12 days ago
(11-Feb-2026)

7/8 (87.5%)

$15.68 (7.49%)

95

Hold Since 23-Feb-2022

$210

$7.59 (3.75%)

$190

12 days ago
(11-Feb-2026)

14/15 (93.33%)

$0.68 (0.32%)

244

Hold Since 23-Jan-2023

$220

$17.59 (8.69%)

$190

12 days ago
(11-Feb-2026)

6/7 (85.71%)

$10.68 (5.10%)

225

Show more analysts

Please expand the browser size to see the chart

Which stock is Ross Muken is most bullish on?

Potential upside of $102 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by Ross Muken?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?